ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TBI vs RCMT // FORWARD P/E MULTIPLE

TrueBlue Inc. (NYSE) VS. RCM Technologies Inc. (NASDAQ) • 15-METRIC TALLY: TBI 2 — RCMT 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TBI VS. RCMT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TBI RCMT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 22.80% 27.50% -4.70 RCMT /gross-margins <GO>
Return on Invested Capital (ROIC) -11.70% 46.00% -57.70 RCMT /roic <GO>
EV/EBITDA & P/E Valuation — 9.5x — TIE /valuation <GO>
Free Cash Flow Yield -24.81% 6.80% -31.61 RCMT /fcf-yield <GO>
Operating Margin -2.90% 7.90% -10.80 RCMT /operating-margins <GO>
Net Profit Margin -3.00% 5.10% -8.10 RCMT /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.73 5.24 -1.51 RCMT /balance-sheet <GO>
Piotroski F-Score Quality 3/9 7/9 -4.00 RCMT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.6 37.1 +23.50 TBI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 14.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $297.1M $255.3M $41.9M TBI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TBI REV RCMT REV TBI GROSS % RCMT GROSS % TBI FCF RCMT FCF
FY 2025 $1.62B $319.4M 22.8% 27.5% -$73.7M $17.4M
FY 2024 $1.57B $278.4M 25.9% 28.7% -$41.2M $3.6M
FY 2023 $0 $0 — — $34.8M $12.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TBI // BETA —
RCMT // BETA —